Iron deficiency anaemia is a global health problem, which particularly affects pregnant women. Iron deficiency anaemia during pregnancy is associated with increased maternal and perinatal morbidity and mortality. Maternal iron deficiency may also be associated with neurocognitive deficits in infants. Iron requirements increase during pregnancy and are influenced by hepcidin, the master regulator of iron homeostasis. The enduring global burden of maternal anaemia suggests that currently employed iron supplementation strategies are suboptimal. Recent developments in our understanding of systemic and placental iron homeostasis may improve therapeutic effectiveness by altering the dose and frequency of oral iron. Intravenous iron appears to be a safe treatment to correct maternal anaemia rapidly but research on patient-centred outcomes and cost-effectiveness is needed. Future trials should be adequately powered to assess outcomes relevant to pregnant women.
TheoV, et al.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet2017;
390: 1211–1259.
2.
StevensGAFinucaneMMDe-RegilLM, et al.
Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health2013;
1: e16–e25.
3.
DaruJCooperNAKhanKS.Systematic review of randomized trials of the effect of iron supplementation on iron stores and oxygen carrying capacity in pregnancy. Acta Obstet Gynecol Scand2016;
95: 270–279.
4.
NairMChurchillDRobinsonS, et al.
Association between maternal haemoglobin and stillbirth: a cohort study among a multi-ethnic population in England. Br J Haematol2017;
179: 829–837.
5.
RahmanMMAbeSKRahmanMS, et al.
Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis. Am J Clin Nutr2016;
103: 495–504.
6.
YoungMF.Maternal anaemia and risk of mortality: a call for action. Lancet Glob Health2018;
6: e479–e480.
7.
NairMChoudhuryMKChoudhurySS, et al.
Association between maternal anaemia and pregnancy outcomes: a cohort study in Assam, India. BMJ Glob Health2016;
1: e000026.
8.
LucasDNBamberJH.UK confidential enquiry into maternal deaths - still learning to save mothers’ lives. Anaesthesia2018;
73: 416–420.
9.
Nelson-PiercyC.The UK maternal death report. Obstet Med2015;
8: 3.
10.
BalarajanYRamakrishnanUOzaltinE, et al.
Anaemia in low-income and middle-income countries. Lancet2011;
378: 2123–2135.
11.
NaikRPLanzkronS.Baby on board: what you need to know about pregnancy in the hemoglobinopathies. Hematol-Am Soc Hematol Educ Program2012;
2012: 208–214.
12.
DevaliaVHamiltonMSMolloyAM,
British Committee for Standards in Hematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol2014;
166: 496–513.
13.
RoyNBAPavordS.The management of anaemia and haematinic deficiencies in pregnancy and post-partum. Transfus Med2018;
28: 107–116.
14.
TolentinoKFriedmanJF.An update on anemia in less developed countries. Am J Trop Med Hyg2007;
77: 44–51.
15.
ZhangC.Essential functions of iron-requiring proteins in DNA replication, repair and cell cycle control. Protein Cell2014;
5: 750–760.
16.
GanzT.Systemic iron homeostasis. Physiol Rev2013;
93: 1721–1741.
17.
FriseMCChengHYNickolAH, et al.
Clinical iron deficiency disturbs normal human responses to hypoxia. J Clin Invest2016;
126: 2139–2150.
18.
FriseMCRobbinsPA.Iron, oxygen, and the pulmonary circulation. J Appl Physiol2015;
119: 1421–1431.
19.
DrakesmithHPrenticeAM.Hepcidin and the iron-infection axis. Science2012;
338: 768–772.
20.
KoenigMDTussing-HumphreysLDayJ, et al.
Hepcidin and iron homeostasis during pregnancy. Nutrients2014;
6: 3062–3083.
21.
BothwellTH.Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr2000;
72: 257S–264S.
22.
FisherALNemethE.Iron homeostasis during pregnancy. Am J Clin Nutr2017;
106: 1567S–1574S.
23.
SangkhaeVFisherALWongS, et al.
Effects of maternal iron status on placental and fetal iron homeostasis. J Clin Invest2020;
130: 625–640.
24.
BahAPasrichaSRJallowMW, et al.
Serum hepcidin concentrations decline during pregnancy and may identify iron deficiency: analysis of a longitudinal pregnancy cohort in the Gambia. J Nutr2017;
147: 1131–1137.
25.
van SantenSKrootJJZijderveldG, et al.
The iron regulatory hormone hepcidin is decreased in pregnancy: a prospective longitudinal study. Clin Chem Lab Med2013;
51: 1395–1401.
26.
RehuMPunnonenKOstlandV, et al.
Maternal serum hepcidin is low at term and independent of cord blood iron status. Eur J Haematol2010;
85: 345–352.
27.
ChurchillDNairMStanworthSJ, et al.
The change in haemoglobin concentration between the first and third trimesters of pregnancy: a population study. BMC Pregnancy Childb2019;
19: 359.
28.
CostantineMM.Physiologic and pharmacokinetic changes in pregnancy. Front Pharmacol2014;
5: 65.
29.
de HaasSGhossein-DohaCvan KuijkSM, et al.
Physiological adaptation of maternal plasma volume during pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol2017;
49: 177–187.
30.
PasrichaSRColmanKCenteno-TablanteE, et al.
Revisiting WHO haemoglobin thresholds to define anaemia in clinical medicine and public health. Lancet Haematol2018;
5: e60–e62.
31.
DaruJSobhySPavordS.Revisiting the basis for haemoglobin screening in pregnancy. Curr Opin Obstet Gynecol2019;
31: 388–392.
32.
ButcherARichardsTStanworthSJ, et al.
Diagnostic criteria for pre-operative anaemia-time to end sex discrimination. Anaesthesia2017;
72: 811–814.
33.
MunozMAchesonAGAuerbachM, et al.
International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia2017;
72: 233–247.
34.
PavordSDaruJPrasannanN, et al.
UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol2020;
188: 819–830.
35.
DaruJColmanKStanworthSJ, et al.
Serum ferritin as an indicator of iron status: what do we need to know?Am J Clin Nutr2017;
106: 1634S–1639S.
36.
van den BroekNRLetskyEAWhiteSA, et al.
Iron status in pregnant women: which measurements are valid?Br J Haematol1998;
103: 817–824.
37.
HallbergLBengtssonCLapidusL, et al.
Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol1993;
85: 787–798.
38.
ChoiJWImMWPaiSH.Serum transferrin receptor concentrations during normal pregnancy. Clin Chem2000;
46: 725–727.
39.
VoraSMMessinaGPavordS.Utility of erythrocyte indices in identifying iron deficiency in pregnancy. Obstet Med. Epub ahead of print 8 November 2019. DOI: 10.1177/1753495X19878617.
40.
PasrichaSRAtkinsonSHArmitageAE, et al.
Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med2014;
6: 235re3.
41.
ShahAWrayKJamesT, et al.
Serum hepcidin potentially identifies iron deficiency in survivors of critical illness at the time of hospital discharge. Br J Haematol2019;
184: 279–281.
42.
PrattJJKhanKS.Non-anaemic iron deficiency - a disease looking for recognition of diagnosis: a systematic review. Eur J Haematol2016;
96: 618–628.
43.
AuerbachMAbernathyJJuulS, et al.
Prevalence of iron deficiency in first trimester, nonanemic pregnant women. J Matern Fetal Neonatal Med2019; 1–4.
44.
HoustonBLHurrieDGrahamJ, et al.
Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: a systematic review of randomised controlled trials. BMJ Open2018;
8: e019240.
45.
MilesLFSandhuRNGroblerAC, et al.
Associations between non-anaemic iron deficiency and outcomes following surgery for colorectal cancer: an exploratory study of outcomes relevant to prospective observational studies. Anaesth Intensive Care2019;
47: 152–159.
46.
MilesLFKunzSANaLH, et al.
Postoperative outcomes following cardiac surgery in non-anaemic iron-replete and iron-deficient patients - an exploratory study. Anaesthesia2018;
73: 450–458.
47.
BlackREVictoraCGWalkerSP, et al.
Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet2013;
382: 427–451.
48.
SayLChouDGemmillA, et al.
Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health2014;
2: e323–e333.
49.
DaruJZamoraJFernandez-FelixBM, et al.
Risk of maternal mortality in women with severe anaemia during pregnancy and post partum: a multilevel analysis. Lancet Glob Health2018;
6: e548–e554.
50.
KavleJAStoltzfusRJWitterF, et al.
Association between anaemia during pregnancy and blood loss at and after delivery among women with vaginal births in Pemba Island, Zanzibar, Tanzania. J Health Popul Nutr2008;
26: 232–240.
51.
BrileyASeedPTTydemanG, et al.
Reporting errors, incidence and risk factors for postpartum haemorrhage and progression to severe PPH: a prospective observational study. BJOG2014;
121: 876–888.
52.
CorwinEJMurray-KolbLEBeardJL.Low hemoglobin level is a risk factor for postpartum depression. J Nutr2003;
133: 4139–4142.
53.
MaedaYOgawaKMorisakiN, et al.
Association between perinatal anemia and postpartum depression: a prospective cohort study of Japanese women. Int J Gynaecol Obstet2020;
148: 48–52.
54.
WassefANguyenQDSt-AndreM.Anaemia and depletion of iron stores as risk factors for postpartum depression: a literature review. J Psychosom Obstet Gynaecol2019;
40: 19–28.
55.
LeeKAZaffkeME.Longitudinal changes in fatigue and energy during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs1999;
28: 183–191.
56.
BeardJLHendricksMKPerezEM, et al.
Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr2005;
135: 267–272.
57.
HenlySJAndersonCMAveryMD, et al.
Anemia and insufficient milk in first-time mothers. Birth1995;
22: 86–92.
58.
RiouxFMSavoieNAllardJ.Is there a link between postpartum anemia and discontinuation of breastfeeding?Can J Diet Pract Res2006;
67: 72–76.
59.
SultanPBampoeSShahR, et al.
Oral vs intravenous iron therapy for postpartum anemia: a systematic review and meta-analysis. Am J Obstet Gynecol2019;
221: 19–29.
60.
HaiderBAOlofinIWangM, et al.
Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ2013;
346: f3443.
61.
AlwanNACadeJEMcArdleHJ, et al.
Maternal iron status in early pregnancy and birth outcomes: insights from the Baby’s Vascular health and Iron in Pregnancy study. Br J Nutr2015;
113: 1985–1992.
62.
RadlowskiECJohnsonRW.Perinatal iron deficiency and neurocognitive development. Front Hum Neurosci2013;
7: 585.
63.
ZhangYShiJWeiH, et al.
Neonate and infant brain development from birth to 2 years assessed using MRI-based quantitative susceptibility mapping. Neuroimage2019;
185: 349–360.
64.
KnickmeyerRCGouttardSKangC, et al.
A structural MRI study of human brain development from birth to 2 years. J Neurosci2008;
28: 12176–12182.
65.
DoomJRGeorgieffMK.Striking while the iron is hot: understanding the biological and neurodevelopmental effects of iron deficiency to optimize intervention in early childhood. Curr Pediatr Rep2014;
2: 291–298.
66.
CarlsonESSteadJDNealCR, et al.
Perinatal iron deficiency results in altered developmental expression of genes mediating energy metabolism and neuronal morphogenesis in hippocampus. Hippocampus2007;
17: 679–691.
67.
AminSBOrlandoMEddinsA, et al.
In utero iron status and auditory neural maturation in premature infants as evaluated by auditory brainstem response. J Pediatr2010;
156: 377–381.
68.
TamuraTGoldenbergRLHouJ, et al.
Cord serum ferritin concentrations and mental and psychomotor development of children at five years of age. J Pediatr2002;
140: 165–170.
69.
ChristianPMurray-KolbLEKhatrySK, et al.
Prenatal micronutrient supplementation and intellectual and motor function in early school-aged children in Nepal. JAMA2010;
304: 2716–2723.
70.
PasrichaSRDrakesmithHBlackJ, et al.
Control of iron deficiency anemia in low- and middle-income countries. Blood2013;
121: 2607–2617.
71.
MunozMPena-RosasJPRobinsonS, et al.
Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med2018;
28: 22–39.
72.
BreymannCBianXMBlanco-CapitoLR, et al.
Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region. J Perinat Med2011;
39: 113–121.
73.
American College of Obstetricians and Gynecologists.ACOG Practice Bulletin No. 95: anemia in pregnancy. Obstet Gynecol2008;
112: 201–207.
74.
PavordSMyersBRobinsonS, et al.
UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol2012;
156: 588–600.
75.
Pena-RosasJPDe-RegilLMDowswellT, et al.Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev2012;
7: CD009997.
76.
TuncalpOPena-RosasJPLawrieT, et al.
WHO recommendations on antenatal care for a positive pregnancy experience – going beyond survival. BJOG2017;
124: 860–862.
77.
MorettiDGoedeJSZederC, et al.
Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood2015;
126: 1981–1989.
78.
StoffelNUCercamondiCIBrittenhamG, et al.
Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol2017;
4: e524–e533.
79.
TolkienZStecherSManderAP, et al.
Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS ONE2015;
10: e0117383.
80.
SchaapCCHendriksJCKortmanGA, et al.
Diurnal rhythm rather than dietary iron mediates daily hepcidin variations. Clin Chem2013;
59: 527–535.
81.
TapieroHGateLTewKD.Iron: deficiencies and requirements. Biomed Pharmacother2001;
55: 324–332.
82.
ClevengerBGurusamyKKleinAA, et al.
Systematic review and meta-analysis of iron therapy in anaemic adults without chronic kidney disease: updated and abridged Cochrane review. Eur J Heart Fail2016;
18: 774–785.
83.
LittonEXiaoJHoKM.Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ2013;
347: f4822.
84.
LewkowitzAKGuptaASimonL, et al.
Intravenous compared with oral iron for the treatment of iron-deficiency anemia in pregnancy: a systematic review and meta-analysis. J Perinatol2019;
39: 519–532.
85.
QassimAGrivellRMHenryA, et al.
Intravenous or oral iron for treating iron deficiency anaemia during pregnancy: systematic review and meta-analysis. Med J Aust2019;
211: 367–373.
86.
KalraPABhandariS.Efficacy and safety of iron isomaltoside (Monofer) in the management of patients with iron deficiency anemia. Int J Nephrol Renovasc Dis2016;
9: 53–64.
87.
KeatingGM.Ferric carboxymaltose: a review of its use in iron deficiency. Drugs2015;
75: 101–127.
88.
EhlkenBNathellLGohlkeA, et al.
Evaluation of the reported rates of severe hypersensitivity reactions associated with ferric carboxymaltose and iron (III) isomaltoside 1000 in Europe based on data from Eudravigilance and Vigibase between 2014 and 2017. Drug Saf2019;
42: 463–471.
89.
MyersBMyersOMooreJ.Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancy. Obstet Med2012;
5: 105–107.
HuangLLLeeDTrosterSM, et al.
A controlled study of the effects of ferric carboxymaltose on bone and haematinic biomarkers in chronic kidney disease and pregnancy. Nephrol Dial Transplant2018;
33: 1628–1635.
92.
El-ZaatariMSHassan-SmithZKReddy-KolanuV.Extravasation and pigmentation post iron infusion. Br J Hosp Med (Lond). Epub ahead of print 2 April 2019. DOI: 10.12968/hmed.2019.80.4.ii.
93.
AvniTBieberAGrossmanA, et al.
The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc2015;
90: 12–23.
94.
ShahAFisherSAWongH, et al.
Safety and efficacy of iron therapy on reducing red blood cell transfusion requirements and treating anaemia in critically ill adults: a systematic review with meta-analysis and trial sequential analysis. J Crit Care2019;
49: 162–171.
95.
HolmCThomsenLLLanghoff-RoosJ. Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage. J Matern Fetal Neonatal Med2018;
32: 2797–2804.
96.
DelaneyMWendelSBercovitzRS, et al.
Transfusion reactions: prevention, diagnosis, and treatment. Lancet2016;
388: 2825–2836.
97.
ParkerJABarrosoFStanworthSJ, et al.
Gaps in the evidence for prevention and treatment of maternal anaemia: a review of systematic reviews. BMC Pregnancy Childb2012;
12: 56.
98.
BahAMuhammadAKWegmullerR, et al.
Hepcidin-guided screen-and-treat interventions against iron-deficiency anaemia in pregnancy: a randomised controlled trial in The Gambia. Lancet Glob Health2019;
7: e1564–e1574.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
